These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1199 related articles for article (PubMed ID: 8826915)

  • 1. Relapse of acute myelogenous leukemia during low dose interleukin-2 (IL-2) therapy. Phenotypic evolution associated with strong expression of the IL-2 receptor alpha chain.
    Spiekermann K; O'Brien S; Estey E
    Cancer; 1995 Apr; 75(7):1594-7. PubMed ID: 8826915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I trial of humanized monoclonal antibody HuM195 (anti-CD33) with low-dose interleukin 2 in acute myelogenous leukemia.
    Kossman SE; Scheinberg DA; Jurcic JG; Jimenez J; Caron PC
    Clin Cancer Res; 1999 Oct; 5(10):2748-55. PubMed ID: 10537338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquisition of CD13 and CD33 expression at relapse on acute myeloid leukemia cells with an unusual phenotype: MPO+CD13-CD33-.
    Kawada H; Ichikawa Y; Kobayashi N; Fukuda R; Yonekura S; Nagao T
    Intern Med; 1993 Sep; 32(9):733-6. PubMed ID: 7908235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine and interleukin-2 in acute myelogenous leukemia.
    Hellstrand K; Mellqvist UH; Wallhult E; Carneskog J; Kimby E; Celsing F; Brune M
    Leuk Lymphoma; 1997 Nov; 27(5-6):429-38. PubMed ID: 9477124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission maintenance therapy with histamine and interleukin-2 in acute myelogenous leukaemia.
    Brune M; Hellstrand K
    Br J Haematol; 1996 Mar; 92(3):620-6. PubMed ID: 8616026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myeloid leukaemia relapsing following interleukin-2 treatment expresses the alpha chain of the interleukin-2 receptor.
    Macdonald D; Jiang YZ; Swirsky D; Vulliamy T; Morilla R; Bungey J; Barrett AJ
    Br J Haematol; 1991 Jan; 77(1):43-9. PubMed ID: 1998596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of IL-3Ralpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis.
    Testa U; Riccioni R; Militi S; Coccia E; Stellacci E; Samoggia P; Latagliata R; Mariani G; Rossini A; Battistini A; Lo-Coco F; Peschle C
    Blood; 2002 Oct; 100(8):2980-8. PubMed ID: 12351411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility, toxicity, and biologic response of interleukin-2 after consolidation chemotherapy for acute myelogenous leukemia: a report from the Children's Cancer Group.
    Sievers EL; Lange BJ; Sondel PM; Krailo MD; Gan J; Liu-Mares W; Feig SA
    J Clin Oncol; 1998 Mar; 16(3):914-9. PubMed ID: 9508173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 2 treatment in acute myelogenous leukemia.
    Mandelli F; Vignetti M; Tosti S; Andrizzi C; Foa R; Meloni G
    Stem Cells; 1993 Jul; 11(4):263-8. PubMed ID: 8401249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
    Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2 receptor alpha chain on acute myelocytic leukemia cells is involved in cell-to-cell interactions.
    Nakase K; Kita K; Otsuji A; Anazawa H; Shirakawa S; Nasu K; Dohy H; Tsutani H; Tanaka I
    Leuk Res; 1993 Jan; 17(1):17-21. PubMed ID: 8429675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of gamma-irradiation on acute myelogenous leukemia blasts: in vitro studies of proliferation, constitutive cytokine secretion, and accessory cell function during T cell activation.
    Bruserud O; Ulvestad E
    J Hematother Stem Cell Res; 1999 Aug; 8(4):431-41. PubMed ID: 10634181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential responses of CD34-positive acute myelogenous leukemic blasts to the costimulating effects of stem cell factor with GM-CSF and/or IL-3.
    Min YH; Lee ST; Lee BK; Chong SY; Lee S; Hahn JS; Ko YW
    Yonsei Med J; 1995 Mar; 36(1):26-36. PubMed ID: 7537932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Children's cancer group trials of interleukin-2 therapy to prevent relapse of acute myelogenous leukemia.
    Sievers EL; Lange BJ; Sondel PM; Krailo MD; Gan J; Tjoa T; Liu-Mares W; Feig SA
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S39-44. PubMed ID: 10685657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myeloid leukemia possibly producing thrombopoietic factor(s).
    Fujita A; Matsuoka M; Shimonaka Y; Imai N; Asano S
    Jpn J Clin Oncol; 1993 Dec; 23(6):366-72. PubMed ID: 7506802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of interleukin-6 in patients with smoldering relapse of acute myelogenous leukemia.
    Estey E; Andreeff M
    Leukemia; 1995 Sep; 9(9):1440-3. PubMed ID: 7658709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth of certain myeloid leukemic cells can be stimulated by interleukin-2.
    Tanaka M
    Growth Factors; 1991; 5(3):191-9. PubMed ID: 1777232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface expression of ICAM-1 (CD54) and LFA-3 (CD58), two adhesion molecules, is up-regulated on bone marrow leukemic blasts after in vivo administration of high-dose recombinant interleukin-2.
    Olive D; Lopez M; Blaise D; Viens P; Stoppa AM; Brandely M; Mawas C; Mannoni P; Maraninchi D
    J Immunother (1991); 1991 Dec; 10(6):412-7. PubMed ID: 1722705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha (p55) and beta (p75) chains of the interleukin-2 receptor are expressed by AML blasts.
    Pizzolo G; Rigo A; Zanotti R; Vinante F; Vincenzi C; Cassatella M; Carra G; Castaman G; Chilosi M; Semenzato G
    Leukemia; 1993 Mar; 7(3):418-25. PubMed ID: 8445947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of thrombopoietin on acute myelogenous leukemia blasts.
    Tokunaga Y; Miyamoto T; Gondo H; Okamura T; Niho Y
    Leuk Lymphoma; 2000 Mar; 37(1-2):27-37. PubMed ID: 10721767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.